0001209191-15-067186.txt : 20150820 0001209191-15-067186.hdr.sgml : 20150820 20150820181352 ACCESSION NUMBER: 0001209191-15-067186 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150820 FILED AS OF DATE: 20150820 DATE AS OF CHANGE: 20150820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562020050 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6507450655 MAIL ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Payne Fletcher CENTRAL INDEX KEY: 0001650476 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 151067192 MAIL ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-20 0 0001124105 CATALYST BIOSCIENCES, INC. CBIO 0001650476 Payne Fletcher 260 LITTLEFIELD AVNUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer Common Stock 2015-08-20 4 J 0 15032 A 15032 I By Charles and Nancy Payne 2000 Trust Stock Option (Right to Buy) 7.60 2015-08-20 4 J 0 7320 A 2025-01-22 Common Stock 7320 7320 D Stock Option (Right to Buy) 7.60 2015-08-20 4 J 0 2440 A 2025-01-22 Common Stock 2440 2440 D Stock Option (Right to Buy) 6.03 2015-08-20 4 J 0 14325 A 2025-05-08 Common Stock 14325 14325 D Represents shares of the Issuer issued pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 5, 2015 as amended on May 6 and May 13, 2015, by and among the Issuer, Talos Merger Sub, Inc. and a Delaware corporation then known as Catalyst Biosciences, Inc. ("Old Catalyst"). Pursuant to the terms of the Merger Agreement, each share of common stock of Old Catalyst was converted into 0.0382 shares of the Issuer's common stock. On January 22, 2015, Reporting Person was granted an option to purchase 191,635 shares of the common stock of Old Catalyst under Old Catalyst's Out of Plan Options at an exercise price of $0.29 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 7,320 shares of the Catalyst's common stock at a per share exercise price of $7.60. The option is fully vested and exercisable. On January 22, 2015, Reporting Person was granted an option to purchase 63,878 shares of the common stock of Old Catalyst under Old Catalyst's Out of Plan Options at an exercise price of $0.29 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 2,440 shares of the Catalyst's common stock at a per share exercise price of $7.60. The option is fully vested and exercisable. On May 8, 2015, Reporting Person was granted an option to purchase 375,000 shares of the common stock of Old Catalyst under Old Catalyst's Out of Plan Options at an exercise price of $0.23 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 14,325 shares of the Catalyst's common stock at a per share exercise price of $6.03. Subject generally to the Reporting Person's continued employment, the option vests at the rate of 1/48th of the number of shares on the 1st of each month with the first month vesting on May 1, 2015. /s/ Nassim Usman Attorney-in-Fact for Fletcher Payne 2015-08-20